021-51111890
购物车（）
sales@molnova.cn
Trifolirhizin
CAS No. 6807-83-6
Trifolirhizin ( —— )
产品货号. M18989 CAS No. 6807-83-6
Trifolirhizin 是从苦参根中分离出的一种 pterocarpan 黄酮类化合物。Trifolirhizin 具有高效的 tyrosinase 抑制活性，IC50 为 506 μM。Trifolirhizin 具有潜在的抗炎和抗癌活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥780 | 有现货 |
|
| 10MG | ￥1321 | 有现货 |
|
| 25MG | ￥2279 | 有现货 |
|
| 50MG | ￥3618 | 有现货 |
|
| 100MG | ￥5013 | 有现货 |
|
| 500MG | ￥10170 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Trifolirhizin
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Trifolirhizin 是从苦参根中分离出的一种 pterocarpan 黄酮类化合物。Trifolirhizin 具有高效的 tyrosinase 抑制活性，IC50 为 506 μM。Trifolirhizin 具有潜在的抗炎和抗癌活性。
-
产品描述Trifolirhizin exerts varying degrees of inhibition on tyrosinase-dependent melanin biosynthesis, and therefore, are candidates as skin-whitening agents.Trifolirhizin possesses potential anti-inflammatory and anti-cancer activities.Trifolirhizin shows in vitro inhibitory effects on the growth of human A2780 ovarian and H23 lung cancer cells. Trifolirhizin inhibits acetylcholine mediated airway smooth muscle (ASM) contraction or directly relaxes pre-contracted ASM independent of β 2 -adrenoceptors.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others|TNF-α
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number6807-83-6
-
分子量446.4
-
分子式C22H22O10
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (224.01 mM)
-
SMILESOC[C@H]6O[C@@H](Oc1cc2OC[C@H]3c4cc5OCOc5cc4O[C@H]3c2cc1)[C@H](O)[C@@H](O)[C@@H]6O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yang N, Liang B, et al.The Sophora flavescens flavonoid compound trifolirhizin inhibits acetylcholine induced airway smooth muscle contraction.Phytochemistry. 2013 Nov;95:259-267.
产品手册
关联产品
-
TRAP-7;Thrombin Rece...
TRAP-7 是一种凝血酶受体 (PAR) 激活肽。TRAP-7 可刺激总肌醇磷酸 (IP) 的积累，并诱导 PKC 的特定内源底物磷酸化。TRAP-7 可用于心血管疾病的研究。
-
Pegamine
pegamine is a natural product found in Peganum harmala and Peganum nigellastrum, which are novel alkaloids.
-
((3S,5R)-5-((1H-1,2,...
((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate is a pharmaceutical intermediate used in the synthesis of posaconazole with anticancer activity.
